# EDGAR Filing Document

**Accession Number:** 0001735438
**File Stem:** 0001104659-26-074085
**Filing Date:** 2026-6
**Character Count:** 5502
**Document Hash:** e6278c1633f96a28bf53e2bb3f7ffb5c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-074085.hdr.sgml**: 20260615

**ACCESSION NUMBER**: 0001104659-26-074085

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 11

**CONFORMED PERIOD OF REPORT**: 20260611

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20260615

**DATE AS OF CHANGE**: 20260615

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MeiraGTx Holdings plc
- **CENTRAL INDEX KEY:** 0001735438
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 981448305
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38520
- **FILM NUMBER:** 261091383

**BUSINESS ADDRESS:**
- **STREET 1:** 655 THIRD AVENUE
- **STREET 2:** SUITE 1115
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 646-860-7985

**MAIL ADDRESS:**
- **STREET 1:** 655 THIRD AVENUE
- **STREET 2:** SUITE 1115
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

?xml version='1.0' encoding='ASCII'? MeiraGTx Holdings plc_June 11, 2026

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**Current Report Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **June 11, 2026**

**MeiraGTx Holdings plc**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Cayman Islands**  | **001-38520** | **98-1448305** |
| (State or other jurisdiction of incorporation or organization)  | (Commission File Number)  | (I.R.S. Employer Identification No.) |

---

**655 Third Avenue, Suite 1115**

**New York, NY 10017**

(Address of principal executive offices) (Zip code)

**(646) 860-7985**

(Registrant's telephone number, including area code)

**Not applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

---

| |
|:---|
| ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  |
| ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  |
| ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))  |

---

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **TradingSymbol(s)** | **Name of each exchangeon which registered** |
| **Ordinary Shares, $0.00003881 par** <br>**value per share** | **MGTX** | **The Nasdaq Global Select Market** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.07** **Submission of Matters to a Vote of Security Holders.**

On June 11, 2026, MeiraGTx Holdings plc (the "Company") held its annual general meeting of shareholders (the "Annual Meeting"). A total of 75,326,022 of the Company's ordinary shares were present in person or represented by proxy at the Annual Meeting, representing approximately 81.4% of the Company's ordinary shares outstanding as of the April 21, 2026 record date. Following are the voting results for the proposals considered and voted upon at the Annual Meeting, each of which were described in the Company's Definitive Proxy Statement filed with the Securities and Exchange Commission on April 30, 2026.

Item 1 – Election of three Class II directors to hold office until the Company's annual general meeting of shareholders to be held in 2029 and until their respective successors have been duly elected and qualified.

---

| | | | |
|:---|:---|:---|:---|
|  | FOR | WITHHELD | BROKER NON-VOTES |
| Ellen Hukkelhoven, Ph.D | 63,644,550 | 246,847 | 11,434,625 |
| Nicole Seligman | 62,881,518 | 1,009,879 | 11,434.625 |
| Debra Yu, M.D. | 54,192,550 | 9,698,847 | 11,434,625 |

---

Item 2 – Ratification, by ordinary resolution, of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.

---

| | | |
|:---|:---|:---|
| FOR | AGAINST | ABSTAINED |
| 73,933,288 | 1,029,075 | 363,659 |

---

Based on the above voting results, the director nominees named above were elected and Item 2 was approved.

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: June 15, 2026 |  |  |
|  | MEIRAGTX HOLDINGS PLC | MEIRAGTX HOLDINGS PLC |
|  | By: | /s/ Richard Giroux |
|  | Name: | Richard Giroux |
|  | Title: | Chief Financial Officer and Chief Operating Officer |

---